Publicerat: 2026-01-02 07:16:32

Detta är en nyhet från nyhetsbyrån Finwire Disclaimer


Finwire om Bio-Works Technologies AB: Bio-Works significantly increased both billings and order intake in Q4

The biotechnology company Bio-Works had billings of SEK 23.7 million (2.6) and order intake of SEK 25.6 million (6.1) in the fourth quarter, according to a business update.Looking at the past two and four quarters, billings were SEK 40.4 million (12.5) and SEK 62.5 million (25.5), respectively.The order book amounted to SEK 32.5 million at year-end.All figures are preliminary.The company is presenting the figures after deciding that, going forward, it will announce sales, order book and order intake immediately after the end of each quarter.

Läs mer om Bio-Works Technologies AB